Objective: To evaluate the role of phosphodiesterase (PDE) activity in the cooling (to 28 °C) and warming (41 °C)-induced effects of carbachol on calf cardiac vein. Material and methods: Rings obtained from calf hearts were suspended in organ baths containing 25 ml of Krebs-Henseleit solution, maintained at 37 °C, continuously gassed with 95%O 2 -5%CO 2 . At the end of the resting period the preparations were contracted with carbachol (10 -9 -3x10 -4 M), at 37 °C. The same protocol was repeated at 28 °C and 41 °C after the preparations were allowed to equilibrate at this temperature for 60 min. In order to analyze the role of PDE activity in the cooling-and warming-induced vascular response, carbachol (10
Contractions of vascular smooth muscles to different agents are modulated by several factors, including temperature. Most of the previous studies examining the effect of temperature on smooth muscle responses to vasoactive agents have focused on the effect of cooling and information on warming is rather limited. Experimental evidence shows that cooling affects reactivity of cutaneous and noncutaneous vessels (1, 2) . It was reported that moderate cooling increased the response of human (3, 4) and dog (5) cutaneous veins to sympathetic nerve stimulation, adrenergic and purinergic agonists. In contrast to the effect of cooling on smooth muscle reactivity to contractile agents, the infl uence of physiologically relevant increases in temperature above 37 ºC on vascular reactivity to vasoactive agents is unclear because of limited information and disparate results. In canine cutaneous veins, heating to temperature above 37 ºC has variable effects on the responses to contractile agents, suggesting that effects of warming may be agent spesifi c (6, 7) . Moreover, Padilla et al. (8) reported that in rabbit femoral artery, warming increased the vasoconstrictor response to potassium, endothelin-1, and norepinephrine, and the characteristics of this increase varied depending on the vasoconstrictor used.
It is known that cyclic nucleotide monophosphates cyclic AMP (cAMP) and cyclic GMP (cGMP) are important endogenous mediators of several processes, including smooth muscle motility (9, 10) . Cyclic nucleotides are synthesized from the corresponding nucleoside triphosphates by the activity of adenylyl and guanylyl cyclases. The increase in cAMP or cGMP triggers a signal transduction cascade encompassing the activation of cyclic nucleotidedependent protein kinases (cAK, cGK), subsequent phosphorylation of the actin-myosin system, as well as Ca 2+ channels and ATP-driven Ca 2+ pumps located in the outer cell membrane or the membrane of the sarcoplasmic reticulum. This cascade leads to a reduction in cytosolic Ca 2+ and, fi nally, to smooth muscle relaxation. Cyclic nucleotides are degraded by phosphodiesterase (PDE) isoenzymes, a heterogeneous group of hydrolytic enzymes. Phosphodiesterases are classifi ed according to their preferences for cAMP or/and cGMP, kinetic parameters of cyclic nucleotide hydrolysis, sensitivity to the inhibition by various compounds, allosteric regulation by other molecules and chromatographic behaviour on anion exchange columns. Eleven families of PDE isoenzymes have been distinguished: Ca 2+ /calmodulin-stimulated PDE (PDE1), cGMP-stimulated PDE (PDE2), cGMP-inhibited PDE (PDE3), cAMP-specifi c PDE (PDE4), cGMP-specifi c PDE (PDE5) and the cGMP-binding, cGMP-specifi c PDE of mammalian rods and cones (PDE6). While PDE7 (cAMP-high affi nity) and PDE8 (IBMX-insensitive) have preferred selectivity for cAMP, PDE9 exclusively degrades cGMP. PDE isoenzymes 10 and 11 can inactivate both cAMP and cGMP. Some of these isoenzyme families consist of more than one gene and some genes are alternatively spliced so that more than 50 isoenzymes or variants have been identifi ed. Some PDE genes are also variably expressed in different tissues (11, 12) . Since the distribution and functional signifi cance of PDE isoenzymes can vary in different tissues, isoenzyme-selective inhibitors have the potential to exert specifi c effects on the target tissue. To date, six out of the 11 PDE isoenzymes have been proven to be of pharmacological importance: PDE1, PDE2, PDE3, PDE4, PDE5 and PDE11 (13) . Phosphodiesterases represent a target for many current pharmacotherapies and as such have major clinical appeal. The major PDEs present in vascular smooth muscles are the cGMP-inhibited PDE (PDE3), the cAMPspecifi c PDE (PDE4), and the major cGMP-hydrolyzing enzyme PDE5 (14-17). The PDE4 family, which specifi cally hydrolyzes cAMP and is insensible to cGMP, is predominantly expressed in myometrium (18) , but also in the smooth muscle of the airways and in infl ammatory cells (19) .
Thus, despite current research to determine the effects of temperature on vascular reactivity of different animal species, studies about PDE activity remain incomplete and there are no studies that analyze the effects of PDE activity on temperature-dependent responses of calf cardiac vein.
The aim of the present study was to determine the role of PDE activity on the cooling and warming-induced responses of calf cardiac vein. For this study, the calf cardiac vein was selected because it is a noncutaneous vessel and is easily accessible. Therefore, a non-selective PDE inhibitor IBMX, a PDE3A inhibitor cilostazol and a PDE4 inhibitor rolipram were used in preparations constricted with carbachol during cooling and warming.
Material and methods

Tissue preparations
Calf hearts were obtained from a slaughterhouse and were immediately placed in Krebs-Henseleit solution. Segments of the great cardiac vein were removed and cut into rings 2.5 mm in length. Care was taken not to damage the endothelium. Each ring was mounted in 25 ml organ baths containing Krebs-Henseleit Solution (KHS), aerated with 95 % O 2 and 5% CO 2 . KHS wascomposed of (mM): NaCl 119, KCl 4.70, MgSO 4 1.50, KH 2 PO 4 1.20, CaCl 2 2.50, NaHCO 3 25, Glucose 11. Changes in isometric tension were recorded by a force-displacement transducer (BIOPAC MP36, Santa Barbara, California, USA) connected through amplifi ers to a ITBS08 Integrated Tissue Bath System (Commat, Ankara, Turkey). The tissues were allowed to equilibrate for 60 min under a resting tension of 1 g with repeated washing every 15 min.
Experimental procedure
First, cumulative concentration-response curves were determined in calf cardiac vein for carbachol (10 -9 -3x10 -4 M) at 37 °C. Then, another set of experiments was designed to determine the effect of cooling on the carbachol-induced contractile responses. After the fi rst concentration-response curve was completed, preparations were washed and allowed to reestablish resting tension before being cooled. When preparations stabilized (30 min), bath temperature was decreased to 28 °C. Preparations were allowed to equilibrate at this temperature for 1 h before a second concentration-response curve was determined. In order to analyse the role of phosphodiesterase activity in the cooling induced vascular response, concentration-response curves to carbachol were obtained in the presence of IBMX (10 -6 M), cilostazol (10 -6 M) and rolipram (10 -6 M), respectively. The preparations were incubated for 20 min with each agent.
In order to analyse the role of PDE activity in the warming induced vascular response, concentration-response curves to carbachol-were obtained at 41 °C.
Only one agent was tested in each preparation.
Statistical analysis
Concentrations of the contractile agents causing 50 % of the maximal response (EC 50 ) were calculated from each individual concentration-response curve. Maximal responses and EC 50 values for curves obtained before (control) and during cooling and warming (control II) and in the presence of IBMX (10 -6 M), cilostazol (10 -6 M) and rolipram (10 -6 M), during cooling and warming were compared by using paired and unpaired Student's t test. Statistical signifi cance was set at p<0.05.
Drugs
Carbachol chloride, IBMX, cilostazol and rolipram were obtained from Sigma (St. Louis, MO, USA). Carbachol chloride was dissolved in distilled water and the stock solutions of others were dissolved in dimethyl sulphoxide; DMSO. Figure 1 shows the effects of carbachol (10 -9 -3x10 -4 M) on calf cardiac vein rings at 37 °C, 28 °C (cooling), and in the presence of IBMX (10 -6 M), cilostazol (10 -6 M) and rolipram (10 -6 M) during cooling. At 37 °C, carbachol produced concentration-dependent contractions. The EC 50 value was found as 5.4±0.3. The sensitivity, but not the maximal response (data not given), of carbachol was signifi cantly lower (4.6 times; p < 0.05) at 28 °C than at 37 °C. Cooling to 28 °C after treatment with IBMX (10 -6 M), cilostazol (10 -6 M) or rolipram (10 -6 M), signifi cantly decreased the sensitivity to carbachol (Tab. 1). Figure 2 shows the effects of carbachol (10 -9 -3x10 -4 M) on calf cardiac vein rings at 37 °C, 41 °C (warming), and in the presence of IBMX (10 -6 M), cilostazol (10 -6 M) and rolipram (10 -6 M), during warming. The sensitivity, but not the maximal response (data not given), of carbachol was signifi cantly higher (7.7 times; p<0.05) at 41 °C than at 37 °C. Warming to 41 °C after treatment with IBMX (10 -6 M), cilostazol (10 -6 M) or rolipram (10 -6 M), signifi cantly decreased the sensitivity to carbachol (Tab. 1).
Results
Discussion
In the present work, we studied the effects of different PDE families in the responses mediated by the cyclic nucleotides in calf cardiac vein during cooling and warming. The precise regulation of the intracellular levels of cyclic nucleotides (cAMP and cGMP) plays an important role in many physiological processes, including vascular smooth muscle contractility (20) .
The cardiac vein is an easily accesible noncutaneous blood vessel and the role of PDE activity on cooling and warming-induced effects of carbachol-induced contractions on this vessel has not been studied before. Coronary venous system (cardiac veins) collects one-third blood of the coronary circulation and is considered to be an important site for the blood-tissue exchange of water and nutrients, as well as a possible determinant of ventricular distensibility. The temperature utilized in this study; 28 °C, for cooling was considered to be "moderate cooling" and 41 °C, "moderate warming" temperature accordingly to previous studies (21) (22) (23) (24) .
In the present study, we investigated the role of PDE activity on the carbachol-induced contractions of calf cardiac vein, during cooling and warming. The results indicate that cooling decreased and warming increased the sensitivity to carbachol. The use of a broad-spectrum PDE inhibitor IBMX, a PDE3 inhibitor cilostazol, the prototype selective PDE4 inhibitor rolipram (25) resulted in a clear reduction in the sensitivity of carbachol during cooling and warming. This suggests that the mechanism of carbachol-induced contraction in calf cardiac vein during cooling and warming involves both PDE3 and PDE4. To my knowledge, this is the fi rst study to show the effects of PDE inhibition of calf cardiac vein contracted with carbachol. In different studies it is reported that cooling (to 28 °C) induced subsensitivity (21) and warming (to 41 °C) induced supersensitivity (22, 23) to carbachol in calf cardiac vein. In these studies, it has also been observed that endothelial nitric oxide does not play a role in the decreased sensitivity of noncutaneous vessels to contractile agents during cooling. However, the mechanism underlying the effects of cooling and warming on noncutaneous vessels to contractile agents is not clear.
As cyclic nucleotides can modulate the vascular smooth muscle tone, the PDEs have become an attractive target for drug development, due to the existence of different PDE isozymes which are differently regulated and distinctly expressed in the cardiovascular system. PDEs hydrolyze cAMP and cGMP and control the concentration of them. The mammalian PDEs are grouped into 11 broad enzyme families that have different structure, biochemical properties, tissue distribution and pharmacological inhibitors.8 Although PDE1, 2, 3, 10, and 11 hydrolyze both cAMP and cGMP; PDE4, 7, and 8 are specifi c for cAMP and PDE5, 6, and 9 are specifi c for cGMP catabolism. PDEs are regulated through a variety of factors. The PDE1 family is the only PDE that is regulated by Ca 2+ / calmodulin. PDE2 is stimulated and PDE3 is inhibited by cGMP. Thus cGMP, via PDE2 and PDE3 can change the balance in the favor of cAMP or itself and plays a critical role in the regulation of cellular cyclic nucleotides levels. PDEs are classifi ed into 11 broad families each having different tissue, cell and subcellular expression (26) . In the cardiac tissues, at least 6 different PDE families have been determined, including PDE1, 2, 3, 4, 5, and 8, which prove vital in the regulation of heart functions in both resting and stimulated conditions. Crosstalk exists between cAMP and cGMP at the activity of PDEs. Increased cGMP could either increase cAMP levels by inhibiting PDE3 or decrease it by stimulating PDE2. Therefore, the relative concentration and compartmentalization of these 2 molecules critically determines cardiac functions (26, 27) .
Cyclic nucleotides regulate fundamental cellular functions in the cardiovascular system. In the heart, intracellular concentrations of cGMP and cAMP controlled by PDEs critically determine cardiac functions (26) . The presence of at least 6 PDEs (PDE1, 2, 3, 4, 5, and 8) was recognized in the heart (26, 27) . However, different expressions and activities of PDE enzymes in the heart have been described among species, tissues, cells and subcellular compartments (28) (29) (30) . In addition, effects of PDEs inhibitors on cardiac functions has been examined in basal and stimulated conditions in different experimental models (30) (31) (32) (33) (34) .
In conclusion, the results of the present study demonstrate for the fi rst time that PDE inhibitors IBMX, cilostazol and rolipram can affect the contractions to carbachol during cooling and warming in calf cardiac vein. Further studies must be performed to clarify the mechanism of cooling and warming-induced responses in calf cardiac vein.
